Natures Sunshine Products Inc.
- NATR · Nasdaq
- Pharmaceutical Preparations
- Lehi, UT
- 806 employees
- CIK 0000275053
Updated from SEC filings through
Top things to know
Executives
- Ken Romanzi CEO of Nature’s Sunshine 8-K, 2026-11-04
-
Kenneth G. Romanzi Chief Executive Officer 4, 2026-05-19 -
Ruth Ann Perkins EVP, Chief Financial Officer 4, 2026-09-15 - Leslie Shane Jones EVP & Chief Financial Officer 4, 2026-05-07
- Jonathan David Lanoy SVP, Chief Accounting Officer 4, 2026-09-03
- Kevin R. Herbert EVP & President, North America 4, 2026-06-29
What leadership is saying
“Our third-quarter results were disappointing and fell short of our expectations”
Earnings press release (8-K Ex. 99.1), filed November 4, 2026
Natures Sunshine Products Inc is a U.S. public company in pharmaceutical preparations (SIC 2834), headquartered in Lehi, UT. It trades as NATR on Nasdaq. Revenue was $480M in the fiscal year ending December 31, 2025, +5.7% from the year before. It reported about 806 employees. Ken Romanzi is CEO of Nature’s Sunshine.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $480M 10-K, 2026-03-10 | $454M 10-K, 2026-03-10 | $445M 10-K, 2025-03-11 | $422M 10-K, 2024-03-12 | $444M 10-K, 2023-03-16 |
| Operating income | $24.7M 10-K, 2026-03-10 | $20.1M 10-K, 2026-03-10 | $18.7M 10-K, 2025-03-11 | $16.3M 10-K, 2024-03-12 | $34.7M 10-K, 2023-03-16 |
| SG&A | $178M 10-K, 2026-03-10 | $164M 10-K, 2026-03-10 | $167M 10-K, 2025-03-11 | $153M 10-K, 2024-03-12 | $154M 10-K, 2023-03-16 |
| Net income | $19.5M 10-K, 2026-03-10 | $7.7M 10-K, 2026-03-10 | $15.1M 10-K, 2025-03-11 | -$390K 10-K, 2024-03-12 | $30.2M 10-K, 2023-03-16 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Ken Romanzi | CEO of Nature’s Sunshine | 8-K, 2026-11-04 |
| Kenneth G. Romanzi | Chief Executive Officer | 4, 2026-05-19 |
| Ruth Ann Perkins | EVP, Chief Financial Officer | 4, 2026-09-15 |
| Leslie Shane Jones | EVP & Chief Financial Officer | 4, 2026-05-07 |
| Jonathan David Lanoy | SVP, Chief Accounting Officer | 4, 2026-09-03 |
| Kevin R. Herbert EVP/President North America Nature's Sunshine | EVP & President, North America | 4, 2026-06-29 |
| Bryant J. Yates EVP and President, Europe, LATAM, and Wholesale at Nature's Sunshine Products | EVP & President, Europe | 4, 2026-06-11 |
| Daniel C. Norman | EVP & President, Asia | 4, 2026-06-03 |
| Kevin Gregory Fuller | Global Chief Marketing Officer | 4, 2026-05-19 |
| Jon Lanoy | Principal Accounting Officer | 8-K, 2026-08-06 |
| Nathan G. Brower | EVP, General Counsel | 4, 2026-05-22 |
| Erich A. Fritz | EVP, Global Supply Chain | 4, 2026-05-19 |
| Jonathan D. Lanoy | Interim Principal Financial Officer | 8-K, 2026-05-11 |
| Martin A. Gonzalez | EVP, Global Supply Chain | 4, 2025-11-06 |
 Heidi Wissmiller | Chairman of the Board and Director | 10-K, 2026-03-10 |
| Curtis Kopf | Director | 10-K, 2026-03-10 |
What Natures Sunshine Products Inc does
We are a natural health and wellness company primarily engaged in the manufacturing and direct selling of nutritional and personal care products. We are a Utah corporation formed in 1976 with our principal place of business in Lehi, Utah. We sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 17.3 million (as of October 23, 2026) | 10-Q, November 4, 2026 |
|---|---|---|
| Public float | $211M (as of June 30, 2025) | 10-K, March 10, 2026 |
| Reportable segments | 4 (period ending September 30, 2026) | 10-Q, November 4, 2026 |
| Latest proxy statement | Meeting March 27, 2026 (filed March 27, 2026) | DEF 14A, March 27, 2026 |
| Auditor | Deloitte & Touche LLP (Salt Lake City, Utah) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| June 12, 2026 | Kevin R. Herbert EVP & President, North America | Sale | 2,000 | $41K | Form 4, June 15, 2026 |
| June 5, 2026 | Bryant J. Yates EVP & President, Europe | Sale | 11,968 | $238K | Form 4, June 11, 2026 |
| June 1, 2026 | Daniel C. Norman EVP & President, Asia | Sale | 9,713 | $200K | Form 4, June 3, 2026 |
| May 21, 2026 | Nathan G. Brower EVP, General Counsel | Sale | 12,015 | $262K | Form 4, May 22, 2026 |
| March 13, 2026 | Bryant J. Yates EVP & President, Europe | Sale | 19,516 | $475K | Form 4, March 17, 2026 |
| March 13, 2026 | Daniel C. Norman EVP & President, Asia | Sale | 15,383 | $377K | Form 4, March 17, 2026 |
| March 13, 2026 | Jonathan David Lanoy SVP, Chief Accounting Officer | Sale | 4,000 | $99K | Form 4, March 16, 2026 |
| December 12, 2025 | Bryant J. Yates EVP & President, Europe | Sale | 1,700 | $38K | Form 4, December 16, 2025 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-06
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-11
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-07
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-03-10
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2025-11-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-10-15
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-07-31
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-07-07
- Item 1.01 Entry into a material definitive agreement
- 8-K filed 2025-06-27
- Item 1.01 Entry into a material definitive agreement
Frequently asked questions about Natures Sunshine Products Inc
- What does Natures Sunshine Products Inc do?
- In its own words, from Item 1 of its 10-K: "We are a natural health and wellness company primarily engaged in the manufacturing and direct selling of nutritional and personal care products. We are a Utah corporation formed in 1976 with our principal place of business in Lehi, Utah. We sell our products to a sales force of independent consultants who use the products themselves or resell them to consumers."
- What is Natures Sunshine Products Inc's revenue?
- $480M for the fiscal year ending December 31, 2025, from its 10-K filed March 10, 2026.
- Is Natures Sunshine Products Inc profitable?
- Natures Sunshine Products Inc reported net income of $19.5M for the fiscal year ending December 31, 2025.
- How many employees does Natures Sunshine Products Inc have?
- About 806 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Natures Sunshine Products Inc?
- Ken Romanzi, CEO of Nature’s Sunshine, as named in a 8-K filed November 4, 2026.
- Who is the CFO of Natures Sunshine Products Inc?
- Ruth Ann Perkins, EVP, Chief Financial Officer, as named in a 4 filed September 15, 2026.
- Where is Natures Sunshine Products Inc headquartered?
- Lehi, UT.
- What is Natures Sunshine Products Inc's stock ticker?
- NATR on Nasdaq.
- What industry is Natures Sunshine Products Inc in?
- Pharmaceutical Preparations, SIC code 2834.
- What is Natures Sunshine Products Inc's website?
- natr.com.
- When does Natures Sunshine Products Inc report earnings next?
- February 3, 2027. Source: estimate_8k_pattern.
- Is Natures Sunshine Products Inc a public company?
- Yes. Natures Sunshine Products Inc files with the SEC under CIK 0000275053 and trades as NATR.
- Who audits Natures Sunshine Products Inc?
- Deloitte & Touche LLP, Salt Lake City, Utah, as named in its latest annual report (10-K).
- How many shares of Natures Sunshine Products Inc are outstanding?
- 17.3 million shares as of October 23, 2026, from its 10-Q filed November 4, 2026.
- What is Natures Sunshine Products Inc's public float?
- $211M as of June 30, 2025, as reported on the cover of its 10-K filed March 10, 2026.
- How many business segments does Natures Sunshine Products Inc report?
- 4 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 4, 2026.
- When is Natures Sunshine Products Inc's annual shareholder meeting?
- March 27, 2026, per its proxy statement (DEF 14A) filed March 27, 2026.
- Have Natures Sunshine Products Inc insiders traded stock recently?
- Since August 13, 2025, officers and directors reported 14 open-market sales worth about $2.5M and 0 purchases on Forms 4 and 5. The most recent: Kevin R. Herbert (EVP & President, North America) sold 2,000 shares on June 12, 2026.